Terms ending in 2028
Every in-force patent on Optinose Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,875,704 | Nasal Administration In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 10,765,829 | Delivery of Gases to the Nasal Airway In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 11,690,969 | Delivery of Gases to the Nasal Airway In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 10,639,438 | Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 11,602,603 | Nasal Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 8,171,929 | Delivery Device and Method In force · High confidence | OptiNose, Inc. | In force | High confidence | |
| US 10,722,667 | Nasal Administration In force · High confidence | OptiNose Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.